Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Medtronic

Last Updated: October 6, 2022

Eurohlth Intl Sarl Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for EUROHLTH INTL SARL, and what generic and branded alternatives to EUROHLTH INTL SARL drugs are available?

EUROHLTH INTL SARL has seven approved drugs.



Summary for Eurohlth Intl Sarl
US Patents:0
Tradenames:7
Ingredients:6
NDAs:7

Drugs and US Patents for Eurohlth Intl Sarl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eurohlth Intl Sarl AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 209337-001 Jun 8, 2020 AP RX No No See Plans and Pricing See Plans and Pricing
Eurohlth Intl Sarl DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride INJECTABLE;INJECTION 083183-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Eurohlth Intl Sarl ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE acyclovir sodium INJECTABLE;INJECTION 074885-001 Dec 19, 1997 DISCN No No See Plans and Pricing See Plans and Pricing
Eurohlth Intl Sarl NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 207042-001 Dec 28, 2015 AP RX No No See Plans and Pricing See Plans and Pricing
Eurohlth Intl Sarl DROPERIDOL droperidol INJECTABLE;INJECTION 208197-001 Dec 14, 2017 AP RX No No See Plans and Pricing See Plans and Pricing
Eurohlth Intl Sarl ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074913-002 Oct 15, 1997 DISCN No No See Plans and Pricing See Plans and Pricing
Eurohlth Intl Sarl NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 207042-002 Dec 28, 2015 AP RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Dow
Colorcon
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.